chr12-124778515-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001082959.2(SCARB1):c.1473G>A(p.Pro491Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0174 in 1,230,548 control chromosomes in the GnomAD database, including 3,453 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.030 ( 512 hom., cov: 33)
Exomes 𝑓: 0.016 ( 2941 hom. )
Consequence
SCARB1
NM_001082959.2 synonymous
NM_001082959.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.08
Genes affected
SCARB1 (HGNC:1664): (scavenger receptor class B member 1) The protein encoded by this gene is a plasma membrane receptor for high density lipoprotein cholesterol (HDL). The encoded protein mediates cholesterol transfer to and from HDL. In addition, this protein is a receptor for hepatitis C virus glycoprotein E2 and facilitates cell entry by the virus, SARS-CoV2. [provided by RefSeq, Oct 2021]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 12-124778515-C-T is Benign according to our data. Variant chr12-124778515-C-T is described in ClinVar as [Benign]. Clinvar id is 1181016.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-124778515-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-3.09 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.379 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCARB1 | NM_005505.5 | c.*72G>A | 3_prime_UTR_variant | 13/13 | ENST00000261693.11 | NP_005496.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCARB1 | ENST00000261693.11 | c.*72G>A | 3_prime_UTR_variant | 13/13 | 1 | NM_005505.5 | ENSP00000261693.6 |
Frequencies
GnomAD3 genomes AF: 0.0302 AC: 4557AN: 150788Hom.: 512 Cov.: 33
GnomAD3 genomes
AF:
AC:
4557
AN:
150788
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0250 AC: 661AN: 26458Hom.: 82 AF XY: 0.0239 AC XY: 317AN XY: 13238
GnomAD3 exomes
AF:
AC:
661
AN:
26458
Hom.:
AF XY:
AC XY:
317
AN XY:
13238
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0155 AC: 16786AN: 1079628Hom.: 2941 Cov.: 32 AF XY: 0.0156 AC XY: 8109AN XY: 521334
GnomAD4 exome
AF:
AC:
16786
AN:
1079628
Hom.:
Cov.:
32
AF XY:
AC XY:
8109
AN XY:
521334
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0302 AC: 4565AN: 150920Hom.: 512 Cov.: 33 AF XY: 0.0348 AC XY: 2568AN XY: 73710
GnomAD4 genome
AF:
AC:
4565
AN:
150920
Hom.:
Cov.:
33
AF XY:
AC XY:
2568
AN XY:
73710
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
535
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 17, 2018 | - - |
SCARB1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 08, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at